Molecular Diagnostics: Completing the Picture. Finding the right treatment for every patient. Integration of proteomic and genomic data is being tested in the clinic. Investments in research will enable additional molecular diagnostics and imaging technologies to enhance the molecular picture of cancer. The more information researchers have, the better equipped they are to identify treatments that will improve outcomes for patients. Solid silhouettes of people are shown in three groups moving down the left side of the graphic. The first group is titled Cancer Identified. On top of this group there are three icons for DNA, mRNA and proteins with a label reading biomarkers analyzed. The second group of figures is labeled Patients Stratified. On top of this group is a label reading Targeted Therapies with lines pointing down to the third group labeled Anticipated Results. This group is divided into two columns labeled benefit and no benefit. The benefit column on the left is much larger. On the right side of the graphic there are three, large icons representing the Genome, Transcriptome, and Proteome. Next to each icon there is text indicating that an individual has between 20,000 to 25,000 genes, approximately 100,000 transcripts, and is estimated to have more than 1 million proteins. At the bottom of the graphic is an illustration of a doctor holding a pen and a clipboard with a piece of paper. Checkmarks are placed on the piece of paper in the pen color next to the icons for the DNA, mRNA and proteins.